Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jul 18, 2025Jul 22, 2025Friedman Paul A
Dir
SellMadrigal Pharmaceuticals, Inc.MDGL$350.03$490,044-0.17%
Jul 16, 2025Jul 18, 2025Friedman Paul A
Dir
SellMadrigal Pharmaceuticals, Inc.MDGL$353.19$10M-3.31%
Apr 08, 2024Apr 11, 2024Friedman Paul A
Dir
SellMadrigal Pharmaceuticals, Inc.MDGL$246.19$6M-3.03%
Apr 03, 2024Apr 06, 2024Friedman Paul A
Dir
SellMadrigal Pharmaceuticals, Inc.MDGL$243.93$18M-8.06%
Aug 02, 2019Aug 06, 2019Friedman Paul A
Dir
SellIncyte CorpINCY$82.69$8M-24.07%
Nov 20, 2018Nov 24, 2018Friedman Paul A
CEO
BuyMadrigal Pharmaceuticals, Inc.MDGL$117.88$471,520+2.42%
Nov 19, 2018Nov 19, 2018Friedman Paul A
CEO
BuyMadrigal Pharmaceuticals, Inc.MDGL$124$496,000+2.48%
Jun 11, 2018Jun 13, 2018Friedman Paul A
CEO
SellMadrigal Pharmaceuticals, Inc.MDGL$287.46$21M-10.08%
Nov 16, 2017Nov 20, 2017Friedman Paul A
Dir
SellIncyte CorpINCY$105.24$3M-9.58%
Mar 16, 2017Mar 20, 2017Friedman Paul A
Dir
SellIncyte CorpINCY$148.72$7M-14.39%
Feb 23, 2017Feb 27, 2017Friedman Paul A
Dir
SellIncyte CorpINCY$120.32$6M-14.39%
Nov 17, 2015Nov 19, 2015Friedman Paul A
Dir
SellIncyte CorpINCY$113.83$26M-43.06%
May 26, 2015May 28, 2015Friedman Paul A
Dir
SellIncyte CorpINCY$107.23$21M-39.81%
May 21, 2015May 26, 2015Friedman Paul A
Dir
SellIncyte CorpINCY$108.22$11M-25.58%
Feb 13, 2015Feb 18, 2015Friedman Paul A
Dir
SellIncyte CorpINCY$74.32$9M-28.74%
Dec 24, 2014Dec 29, 2014Friedman Paul A
Dir
BuyVerastem, Inc.VSTM$8.31$24,932+50.00%
Dec 04, 2014Dec 08, 2014Friedman Paul A
Dir
SellAuxilium Pharmaceuticals IncAUXL$33.73$1M-74.13%
Nov 06, 2014Nov 07, 2014Friedman Paul A
Dir
SellIncyte CorpINCY$67.87$13M-30.78%
Feb 20, 2014Feb 21, 2014Friedman Paul A
Dir
SellIncyte CorpINCY$63.51$2M-7.40%
Feb 14, 2014Feb 19, 2014Friedman Paul A
Dir
SellIncyte CorpINCY$65.65$51M-64.88%
Sep 10, 2013Sep 12, 2013Friedman Paul A
CEO
SellIncyte CorpINCY$37.32$14M-49.02%